← Leaderboards
Priscilla Simon Redd
Chemedimmune, Inc.
$650,207
Attributed
$650,207
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $329.6K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$650,207 · 2
By mechanism
R43$650,207 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Survival Rate”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Phd, Stephen Schwartz · Fred Hutchinson Cancer Research Center$21,360,715
- Scarlett Lin-Gomez · University Of California, San Francisco$18,598,737
- Mary Charlton · University Of Iowa$16,748,573
- Lihua Liu · University Of Southern California$16,229,586
- Eric Durbin · University Of Kentucky$13,607,670
Research focus
Survival RateCytotoxic T-LymphocytesProgrammed Cell Death Ligand 1TumorProteinsImmunotherapyIn VivoNeoplastic CellSignal PathwayT-LymphocyteCancer PatientPublishingMalignant NeoplasmsLiteratureClone CellsChemokineBiodistributionCessation Of LifeCancer TherapyBindingAffinityCt26Curative TreatmentsCovid-19